Clinical trial
A Cross-Sectional Study of Hematotoxicity in Workers Exposed to Formaldehyde
NCT01547858 is registered in ClinicalTrials.gov with National Cancer Institute (NCI) as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Cross-Sectional Study of Hematotoxicity in Workers Exposed to Formaldehyde
- Lead sponsor
- National Cancer Institute (NCI)
- Phase
- Observational
- Overall status
- Completed
- Start date
- February 9, 2012
- Completion date
- November 12, 2020
- Enrollment
- 708 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
blood, chemical industry